95
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Does the eradication of Helicobacter pylori delay the diagnosis of gastric cancer?

, PhD , MD, , , &
Pages 1456-1460 | Received 01 Apr 2008, Published online: 08 Jul 2009

References

  • Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
  • Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Jr, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705–8
  • Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347–53.
  • Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772–81
  • Karvonen AL. Ylävatsavaivan diagnostiikka: pitääkö aina tähystää?. Suomen Lääkärilehti 2005; 44: 4487–90
  • Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB, Tham TC. A prospective randomised trial of a “test and treat” policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999; 45: 186–90
  • Färkkilä M, Sarna S, Valtonen V, Sipponen P, PROSPER Study Group. Does the “test-and-treat” strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. Scand J Gastroenterol 2004;39:327–35.
  • McColl KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. Br Med J 2002; 324: 999–1002
  • Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7-year follow-up of a randomised trial. Gut 2004; 53: 1758–63
  • Stephens MR, Lewis WG, White S, Blackshaw GR, Edwards P, Barry JD, et al. Prognostic significance of alarm symptoms in patients with gastric cancer. Br J Surg 2005; 92: 840–6
  • UICC: TNM classification of malignant tumours, 6th ed. 2002.
  • Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. APMIS 1965; 64: 31–49
  • Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long-term, follow-up study. Gut 2000; 47: 618–21
  • Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000; 46: 464–7
  • Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639–42
  • Nakagawa S, Asaka M, Kato M, Nakamura T, Kato C, Fujioka T, et al. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Aliment Pharmacol Ther 2006; 24(Suppl 4)214–8
  • Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187–94
  • Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007; 25: 805–12
  • Maconi G, Kurihara H, Panizzo V, Russo A, Cristaldi M, Marrelli D, et al. Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol 2003; 38: 1249–55
  • Look M, Tan YY, Vijayan A, Teh CH, Low CH. Management delays for early gastric cancer in a country without mass screening. Hepatogastroenterology 2003; 50: 873–6
  • Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H. Helicobacter pylori, CagA, and parietal cell antibodies and serum pepsinogen I in patients with gastric carcinoma. World J Gastroenterol 2005; 11: 1032–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.